IL144597A0 - Hydrogel particle formulations - Google Patents

Hydrogel particle formulations

Info

Publication number
IL144597A0
IL144597A0 IL14459700A IL14459700A IL144597A0 IL 144597 A0 IL144597 A0 IL 144597A0 IL 14459700 A IL14459700 A IL 14459700A IL 14459700 A IL14459700 A IL 14459700A IL 144597 A0 IL144597 A0 IL 144597A0
Authority
IL
Israel
Prior art keywords
methods
hydrogel particle
particle formulations
new compositions
compositions
Prior art date
Application number
IL14459700A
Other languages
English (en)
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Publication of IL144597A0 publication Critical patent/IL144597A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14459700A 1999-02-03 2000-02-03 Hydrogel particle formulations IL144597A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11833499P 1999-02-03 1999-02-03
PCT/GB2000/000349 WO2000045792A1 (en) 1999-02-03 2000-02-03 Hydrogel particle formulations

Publications (1)

Publication Number Publication Date
IL144597A0 true IL144597A0 (en) 2002-05-23

Family

ID=22377934

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14459700A IL144597A0 (en) 1999-02-03 2000-02-03 Hydrogel particle formulations
IL144597A IL144597A (en) 1999-02-03 2001-07-26 Preparations of hydrogel particles

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144597A IL144597A (en) 1999-02-03 2001-07-26 Preparations of hydrogel particles

Country Status (16)

Country Link
US (1) US7022313B2 (de)
EP (1) EP1146861B1 (de)
JP (1) JP2002536317A (de)
KR (1) KR100845769B1 (de)
CN (1) CN1230152C (de)
AT (1) ATE298562T1 (de)
AU (1) AU780397B2 (de)
BR (1) BR0007974A (de)
CA (1) CA2361555A1 (de)
DE (1) DE60021059T2 (de)
ES (1) ES2243229T3 (de)
IL (2) IL144597A0 (de)
MX (1) MXPA01007844A (de)
NZ (1) NZ513538A (de)
PT (1) PT1146861E (de)
WO (1) WO2000045792A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050214227A1 (en) * 1999-03-08 2005-09-29 Powderject Research Limited Microparticle formulations for sustained-release of bioactive compounds
WO2000053160A1 (en) * 1999-03-08 2000-09-14 Powderject Research Limited Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
US20020051821A1 (en) * 2000-09-08 2002-05-02 Sung-Yun Kwon Aliginate particle formulation
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
US7618565B2 (en) * 2001-08-16 2009-11-17 Polytechnic Institute Of New York University Lipobeads and their production
GB2379390B (en) * 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
KR20050044523A (ko) * 2001-11-19 2005-05-12 벡톤 디킨슨 앤드 컴퍼니 입자 형태의 약제학적 조성물
JP2005522473A (ja) * 2002-04-10 2005-07-28 オブシェストヴォ ス オグラニシェノイ オトヴェトストベノスチユ《ヴィタゲル》 多官能価の生体適合性ヒドロゲル及びその生産方法
EP1356826A1 (de) * 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Mikropartikel die Kohlenhydratkugeln enthalten an welche ein Allergen kovalent gebunden sind
GB0300008D0 (en) * 2003-01-02 2003-02-05 Optinose As Delivery devices
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2005061088A1 (en) * 2003-12-22 2005-07-07 Finlay Warren H Powder formation by atmospheric spray-freeze drying
ITRM20040168A1 (it) * 2004-04-01 2004-07-01 Sigma Tau Ind Farmaceuti Composizione a rilascio modificato ph dipendente.
KR100624450B1 (ko) * 2004-12-10 2006-09-18 삼성전자주식회사 히드로겔을 이용한 생물분자의 분리 및 정제 방법
KR100624452B1 (ko) * 2004-12-21 2006-09-18 삼성전자주식회사 고정화된 히드로겔 또는 ｐｅｇ－히드로겔 공중합체를이용한 핵산의 분리 및 정제 방법
NZ543314A (en) * 2005-10-28 2007-08-31 Interag A delivery system where the driving substance contains the active component
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
EP1981338A2 (de) * 2006-01-13 2008-10-22 Advanced Bionutrition Corporation Produktionssystem mit kontinuierlicher sprühnebelaufnahme
US8257685B2 (en) * 2006-04-04 2012-09-04 Stc.Unm Swellable particles for drug delivery
WO2007144894A1 (en) * 2006-06-15 2007-12-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Hydrocolloid carrier beads with inert filler material
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
JP2008096503A (ja) * 2006-10-06 2008-04-24 Toshiba Corp 粉末状感光性組成物の製造方法、感光性組成物およびこの感光性組成物から形成された光記録媒体
ES2382982T3 (es) 2007-07-21 2012-06-15 Albany Molecular Research, Inc. Indazoles sustituidos con 5-piridinona y composiciones farmacéuticas de los mismos
US8093038B2 (en) * 2007-09-17 2012-01-10 Illinois Institute Of Technology Apparatus and method for encapsulating pancreatic cells
WO2009049089A1 (en) * 2007-10-09 2009-04-16 Washington University In St. Louis Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
EP2209420A4 (de) 2007-10-09 2014-01-22 Univ St Louis Partikel für bildgebung
US8293510B2 (en) * 2007-11-16 2012-10-23 University Of Kansas Method of preparing a hydrogel network encapsulating cells
WO2009067621A1 (en) 2007-11-21 2009-05-28 Decode Genetics Ehf Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
US8716308B2 (en) 2008-01-11 2014-05-06 Albany Molecular Research, Inc. (1-azinone)-substituted pyridoindoles
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
JP5689687B2 (ja) * 2008-03-05 2015-03-25 サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ アジュバント含有ワクチン組成物の安定化方法
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
RU2506266C2 (ru) 2009-01-26 2014-02-10 Израэл Инститьют Фо Байолоджикал Рисерч Бициклические гетероциклические спиросоединения
JP6101077B2 (ja) * 2009-04-20 2017-03-22 ガレンバイオ、インコーポレイテッド 生体分子を細胞へトランスフェクトするための組成物
EP3960215A1 (de) 2009-12-15 2022-03-02 Incept, LLC Implantate und biologisch abbaubare bezugsmarkierungen
US9808500B2 (en) 2009-12-17 2017-11-07 Washington University Antithrombotic nanoparticle
AU2010339809B2 (en) 2009-12-17 2016-05-05 The Washington University Antithrombotic nanoparticle
JP5988435B2 (ja) * 2010-01-24 2016-09-07 ノバルティス アーゲー 放射線照射された生分解性微粒子
JP2013527157A (ja) 2010-04-15 2013-06-27 ワシントン・ユニバーシティ プロドラッグ組成物、プロドラッグナノ粒子およびその使用方法
US8927025B2 (en) 2010-05-11 2015-01-06 Cima Labs Inc. Alcohol-resistant metoprolol-containing extended-release oral dosage forms
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
JP6042815B2 (ja) 2010-10-08 2016-12-14 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
CN103167868B (zh) * 2010-10-14 2016-08-03 株式会社爱茉莉太平洋 包覆有脂质的水凝胶粒子及其制备方法
US10092660B2 (en) * 2011-04-25 2018-10-09 Stc.Unm Solid compositions for pharmaceutical use
KR101255520B1 (ko) * 2011-10-28 2013-04-23 한국과학기술원 이중충하이드로젤 미세입자의 비등방성 부품을 이용한 미세수송체의 제조방법
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
US11426571B2 (en) * 2016-11-18 2022-08-30 Industry-Academic Cooperation Foundation, Yonsei University Microneedle array with composite formulation, and method for manufacturing same
US11980700B2 (en) 2017-03-08 2024-05-14 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
KR102129986B1 (ko) * 2018-08-30 2020-07-03 포항공과대학교 산학협력단 일산화질소 감응성을 갖는 아크릴아마이드계 고분자를 포함하는 염증성 질환 예방 또는 치료용 약학 조성물
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same
WO2020225773A1 (en) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
KR102407470B1 (ko) * 2021-08-09 2022-06-10 인제대학교 산학협력단 하이드로겔에 담지된 약물의 방출량 검출 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
JPH0725689B2 (ja) 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
SE456486B (sv) 1987-03-27 1988-10-10 Ralf Andersson Sett och anordning for uppdelning av en smelta i droppar
US4994276A (en) 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5041292A (en) 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US4925677A (en) 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
EP0500799B1 (de) 1989-11-16 1998-01-14 Duke University Transformation von tierischen Hautzellen mit hilfe von Partikeln
ES2081384T3 (es) * 1990-04-25 1996-03-01 Hoechst Ag Preparado farmaceutico que contiene complejos de polielectrolitos en forma de microparticulas y por lo menos una sustancia activa.
GB9014871D0 (en) * 1990-07-05 1990-08-22 Erba Carlo Spa Drug delivery system for administering growth factor
AU5547594A (en) 1992-11-03 1994-05-24 Secretech, Inc. Microcrystalline cellulose as an immune adjuvant
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5932248A (en) * 1993-11-18 1999-08-03 Paragon Medical Limited Controlled release preparations for cytotoxic or cytostatic drugs
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
JP3853360B2 (ja) 1994-10-24 2006-12-06 パウダージェクト リサーチ リミテッド 粒子供給装置
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
GB9605690D0 (en) 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
GB9619002D0 (en) * 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
WO1998013798A1 (de) 1996-09-26 1998-04-02 Wanzl Metallwarenfabrik Gmbh Einrichtung und verfahren zum einkaufen von ware
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
EP0888790A1 (de) 1997-07-04 1999-01-07 PowderJect Research Limited Vorrichtung zur Abgabe von Medikamententeilchen
EP0888791A1 (de) 1997-07-04 1999-01-07 PowderJect Research Limited Spritze und dafür geeignete Medikamentenkapsel
AU765763B2 (en) 1998-09-04 2003-09-25 Powderject Research Limited Monitoring methods using particle delivery methods
AU765050B2 (en) 1998-09-04 2003-09-04 Powderject Research Limited Immunodiagnostics using particle delivery methods
US5952232A (en) * 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
NZ510928A (en) 1998-10-01 2002-10-25 Powderject Res Ltd Spray coated powder composition formed from seed particles between 10-100 micrometres coated with an aqueous pharmaceutical composition
JP2002535293A (ja) 1999-01-22 2002-10-22 パウダージェクト リサーチ リミテッド 無針の経皮的粉末薬物送達を増強する方法

Also Published As

Publication number Publication date
US20020061336A1 (en) 2002-05-23
MXPA01007844A (es) 2005-06-06
AU2309200A (en) 2000-08-25
CA2361555A1 (en) 2000-08-10
WO2000045792A1 (en) 2000-08-10
EP1146861A1 (de) 2001-10-24
US7022313B2 (en) 2006-04-04
WO2000045792A8 (en) 2001-11-29
DE60021059T2 (de) 2006-05-18
ES2243229T3 (es) 2005-12-01
IL144597A (en) 2007-03-08
JP2002536317A (ja) 2002-10-29
NZ513538A (en) 2004-02-27
KR20010101994A (ko) 2001-11-15
ATE298562T1 (de) 2005-07-15
PT1146861E (pt) 2005-10-31
EP1146861B1 (de) 2005-06-29
AU780397B2 (en) 2005-03-17
BR0007974A (pt) 2001-10-30
DE60021059D1 (de) 2005-08-04
CN1345232A (zh) 2002-04-17
CN1230152C (zh) 2005-12-07
KR100845769B1 (ko) 2008-07-11

Similar Documents

Publication Publication Date Title
IL144597A0 (en) Hydrogel particle formulations
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
EP1093819A3 (de) Verbindungen und Arzneizusammensetzungen zur Verabreichung von Wirkstoffen
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
HK1036969A1 (en) Compounds and compositions for delivering active agents
HK1054918A1 (en) Compounds and compositions for delivering active agents
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
CA2338358A1 (en) Compounds and compositions for delivering active agents
BR0308137A (pt) Formulações de droga de liberação constante contendo um peptìdeo veìculo
IL195055A (en) Carboxylic acid components and compounds for transporting active carriers
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
MY129356A (en) Electrospun pharmaceutical compositions
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
JO2506B1 (en) Dosage titration device in hydrofluoroalkan propellants
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
IL142276A0 (en) Spray coated microparticles for use in needleless syringes
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
DE60115631D1 (de) Halbfester verabreichungsträger und arzneimittel
CO5200854A1 (es) Formulaciones farmaceuticas orales en capsulas de gelatina de hidroxipropilmetil celulosa que comprenden un derivado de camptotecina dentro de una matriz semisolida de polietilenglicol
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor
MX9702899A (es) Compuestos y composiciones para suministrar agentes activos.
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed